Background: Many studies have shown that trans fatty acids have unfavorable effects on the serum lipoprotein profile. In general, however, fats were compared with different functional characteristics, which lower the practical applications of the results. Objective: The major aim of this study was to compare the effects of a high-palmitic acid, trans-free semiliquid fat with those of a high-oleic acid, low-trans semiliquid fat on the serum lipoprotein profile of healthy subjects. Subjects and design: Forty-four subjects (33 women and 11 men) consumed, in random order, two experimental diets, each for 3 weeks. Diets provided 40 energy percent (En%) from fat, while 15 En% was supplied by the experimental fats. At the end of each intervention period, concentrations of serum lipoproteins, C-reactive protein, glucose and insulin were measured. Results: When subjects consumed the high-oleic acid, low-trans semiliquid fat, intakes of stearic acid ( þ 1.3 En%), oleic acid ( þ 2.9 En%), a-linolenic acid ( þ 0.1 En%) and trans fatty acids ( þ 0.6 En%) were higher and that of palmitic acid (À4.2 En%) lower. Serum concentration of low-density lipoprotein cholesterol decreased by 0.3470.39 mmol/l (mean7s.d.; 95% confidence interval (CI), À0.46 to À0.23 mmol/l; Po0.001) and high-density lipoprotein (HDL) cholesterol by À0.0670.17 mmol/l (95% CI, À0.11 to À0.01 mmol/l; P ¼ 0.021). Also, the total to HDL cholesterol ratio was lower (À0.1570.34; 95% CI, À0.25 to À0.05; P ¼ 0.006). Other parameters did not change. Conclusions: A high-oleic acid, low-trans semiliquid fat has a more favorable effect on the serum lipoprotein profile than a transfree semiliquid fat with comparable functional characteristics, but high in palmitic acid.
Introduction
Trans monounsaturated fatty acids from hydrogenated oils increase concentrations of the atherogenic low-density lipoprotein (LDL) particles, when compared with an isocaloric amount of carbohydrates or oleic acid. In this respect, effects between trans monounsaturated fatty acids and palmitic acid (C 16:0 ) are not very different. Palmitic acid, however, increases concentrations of the anti-atherogenic high-density lipoprotein (HDL) cholesterol particles, when compared with trans monounsaturated fatty acids (Mensink et al., 2003) . Also, the total to HDL cholesterol ratio and triacylglycerol concentrations, which are both positively related to cardiovascular risk (Castelli, 1996) , are more beneficially affected by palmitic acid than by trans monounsaturated fatty acids from hydrogenated oils (Mensink et al., 2003) . These findings suggest that substituting hydrogenated oils and semiliquid fats rich in trans monounsaturated fatty acids for oils rich in palmitic acid will lower cardiovascular risk. However, the optimal choice of fats and oils for food preparations does not only depend on their health effects, but also on their functional characteristics. For example, preparation of French fries, snacks, meat and chicken products all require a stable frying oil to prevent as long as possible oxidation and polymerization of the oil. Partially hydrogenated oils fulfill these requirements, but have a high content of trans fatty acids. Palm fruit-based oils have therefore been promoted as a suitable alternative for hydrogenated oils (Muller et al., 1998) . However, the exclusive use of palm oils for frying purposes will result in a substantial and undesirable increase in the consumption of palmitic acid. In fact, the World Health Organization has concluded that there is convincing evidence that the saturates myristic acid and palmitic acid, when consumed in elevated quantities, will increase the risk to develop cardiovascular diseases (Report of a Joint WHO/ FAO Expert Consultation, 2002) . Replacing hydrogenated fats -high in trans fatty acids, but low in palmitic acid -by palm oil, virtually free of trans fatty acids, but high in palmitic acidfor cooking and baking is nevertheless a possibility for several applications such as frying and for the production of low-fat bakery products and snacks. However, there may also be some technological disadvantages in this respect. For example, for some specific food production processes, the crystallization rate, melting curve and the stability of palm oils may not be as good as that of hydrogenated fats.
Recently, a new generation of hydrogenated oils and fats have been developed using novel technologies, resulting in a significant reduction (up to 80%) in trans fatty acid content of oils and fats (Dijkstra, 2006) . In this type of oil, the structuring fatty acid is stearic acid (C 18:0 ), a saturated fatty acid with hardly any impact on LDL cholesterol (Mensink et al, 2003) , while it also has a higher content of oleic acid (cis-C 18:1 ) as compared with the traditional hydrogenated oils. This new development combines a good crystallization rate with a good oxidative stability. Effects of these new types of oils on cardiovascular risk marker have never been studied. We have therefore compared the effects of two semiliquid fats on the serum lipoprotein profile of healthy volunteers. One fat was high in palmitic acid and contained virtually no trans monounsaturated fatty acids. The other semiliquid fat was high in oleic acid and contained a small fraction of trans monounsaturated fatty acids. As recent studies have also indicated that trans monounsaturated fatty acids increases biomarkers of low-grade systemic inflammation (Baer et al., 2004; Mozaffarian et al., 2004; Lopez-Garcia et al., 2005) , effects of the two fats on C-reactive protein (CRP) concentrations were also studied. Finally, effects on glucose and insulin concentrations were examined.
Subjects and methods

Subjects
Healthy men and women were recruited via advertisements in local newspapers and a university hospital newsletter and via posters in university buildings. People who were interested were fully informed about the purposes and requirements of the study. Subjects were invited for two screening visits with an interval of at least 3 days after they had given their written informed consent before they entered the screening procedure. At screening, fasting blood samples were taken for analysis of serum lipid and lipoprotein concentrations, and blood pressure, weight and length were measured. Only at the first screening day, urinary glucose from a morning urine specimen was assessed. Subjects were included in the study if they were aged 18-70 years, healthy as indicated by a medical questionnaire, not pregnant or breast feeding, weight stable and had a body mass index (BMI) below 32 kg/m 2 , a diastolic blood pressure below 95
and systolic blood pressure below 160 mm Hg, no indication for treatment with cholesterol-lowering drugs according to the Dutch Cholesterol Consensus (1998) and a serum triacylglycerol concentration below 4.0 mmol/l. Subjects with a history of atherosclerotic disease or glucosuria or who were using medications known to affect blood lipids were excluded from the study. Blood donation or participation in another biomedical trial was not allowed within 4 weeks before the start of the study or during the study. None of the subjects used vitamin supplements, fish-oil capsules or products enriched with plant sterol or stanol esters within 3 weeks before the start or during the study. , had a systolic blood pressure of 126710.6 and a diastolic blood pressure of 8176.6 mm Hg. For the male subjects, the mean fasting concentrations of serum total cholesterol, LDL cholesterol, HDL cholesterol and triacylglycerol were respectively 5. 4070.64, 3.4770.66, 1.2070.23 and 1.6270 .75 mmol/l. For women, these values were 5.3170.67 for total cholesterol, 3.0570.62 for LDL cholesterol, 1.5470.43 for HDL cholesterol and 1.5670.67 mmol/l for triacylglycerol. Thirteen women were postmenopausal and nine used oral contraceptives. None of the subjects smoked.
Experimental design and diets
The study had a double-blind, randomized, crossover design and consisted of two dietary periods of 3 weeks, interrupted by a washout period of 1 week during which time subjects consumed their habitual diets. One experimental fat was rich in a fat high in palmitic acid, which contained virtually no trans fatty acids (high-palmitic, trans-free diet), while another experimental fat was high in oleic acid and provided a small amount of trans fatty acids (high-oleic acid, low-trans diet). Fats were incorporated into margarines (80% fat (w/w)), cookies (17% fat), muffins (24% fat), chocolate paste (35% fat) and chips (23% fat). Products were letter-coded to blind the subjects and the investigators.
Before the study started, subjects were categorized according to sex and randomly divided into two groups. Each group received the diets in one of the two possible treatment orders.
Before the study started, all subjects completed a food frequency questionnaire to estimate their habitual energy and nutrient intakes. In view of these results, the men received guidelines from the dietician in such a way that the experimental fats supplied 15% of the total energy intake. During the study, subjects recorded in a diary, alcohol consumption, medication used, any sign of illness, menstruation and any deviations from the study protocol were noted. Subjects were asked not to change their level of physical exercise or their use of alcohol, vitamins or oral contraceptives during the study.
During the study periods, volunteers visited the university at least once every week to receive a new supply of products and to be weighed. Products, that were left over, had to be returned and were weighed. At each visit, body weight was measured and a dietician checked the diary. In the last week of each intervention period, subjects filled in a food frequency questionnaire to estimate energy and nutrient intakes. A dietician checked food frequency lists immediately in the presence of the subjects. Items were coded and the composition of the diets was calculated using the Dutch food composition table (Nevo, 2001 ).
Experimental fats
Experimental fats were produced by Cargill (Rotterdam, The Netherlands). The high-palmitic acid, trans-free semiliquid fat was made from palm olein. The high-oleic acid, low-trans semiliquid fat was produced from rapeseed oil via a hardening process that resulted in low levels of trans fatty acids. The fatty acid compositions of the experimental fats were determined by gas-liquid chromatography (Table 1) . For this, about 0.15 g (3-4 droplets) of the liquefied fats was saponified. The resultant fatty acids were methylated into their corresponding fatty acid methyl esters (FAMEs) (Morrison and Smith, 1964) , which were separated on a Chrompack CP9002-series gas chromatograph (Chrompack, Middelburg, The Netherlands), fitted with a 60-m SGE BPX70 polar capillary column (0.25 mm internal diameter, film thickness 0.25 mm). The split ratio was 1:100, the injection temperature 2401C, and the detection temperature 2501C, while helium was used as carrier gas (200 kPa). The starting temperature of the column was 1851C. After 25 min, the temperature was increased up to 2151C within 5 min. The final temperature of 2151C was maintained for 5 min. The FAMEs were detected using a FLAME ionization detector using hydrogen gas. A standard mixture of FAME was used to identify the FAME in the samples by means of retention times. Using computer-assisted analysis (Chrompack Maitre 2.5), the fatty acid profiles were corrected for blank runs. Results were expressed in relative amounts (% of total fatty acids identified, w/w).
The melting point of both fats was around 231C. The solidfat content as measured by p-NMR of the high-palmitic acid, trans-free fat and the high-oleic acid, low-trans fats were respectively 38% and 15% at 101C, 7% and 7% at 201C and 0% and 1% at 301C.
Blood sampling
Venous blood samples with the volunteer in recumbent position were obtained after an overnight fast twice at the end of each period (days 0, 17 and 21). Blood was sampled with minimum stasis by using a 0.9-mm needle (PrecisionGlide, Becton-Dickinson Vacutainer systems, Plymouth, UK). All venipunctures were done by the same person, in the same room and mostly at the same time of the day.
For lipid and lipoprotein analyses, 10 ml of blood was collected in a serum tube (Corvac, Becton Dickinson Vacutainer Systems, Plymouth, UK). At least 1 h after venipuncture, serum was obtained by centrifugation at 3500 g for 30 min at 41C and stored at À801C. For all other analyses, EDTA plasma was used. EDTA tubes (10 ml) (Becton Dickinson Vacutainer Systems) were centrifuged at 3500 g for 30 min within 1 h 43.5 (43.1-44.1) 60.0 (58.6-61.5) Cis-polyunsaturated fatty acids 11.5 (11.4-11.7) 12.0 (11.5-12.5) Linoleic acid (C18:2n-6) 11.0 (10.8-11.1) 11.0 (10.5-11.5) a-Linolenic acid (C18:3n-3) 0.5 (0.3-0.7) 1.0 (0.9-1.1) Trans fatty acids 1.0 (0.7-1.3) 4.5 (3.9-4.7)
Values are expressed as % of total fatty acids and are the average values (minimum, maximum) of five samples.
after venipuncture. Serum and plasma samples were snapfrozen in liquid nitrogen and stored at À801C.
Laboratory measurements
Serum total cholesterol (ABX Diagnostics, Montpellier, France), HDL cholesterol (precipitation method; Roche Diagnostics Corporation, Indianapolis, IN) and triacylglycerol (Sigma Aldrich Chemie, Steinheim, Germany) concentrations were analyzed enzymatically. LDL cholesterol was calculated using the equation of Friedewald (Friedewald et al., 1972) . High-sensitivity CRP (hsCRP) concentrations were measured in pooled EDTA plasma samples of days 17 and 21 by an immunoturbidimetric assay (K-ASSAY CRP-2, Kamiya Biomedical Company, Seattle, WA) as described previously (Huddleston et al., 2001) . EDTA plasma of days 17 and 21 was used to measure glucose (Boehringer Mannheim, Mannheim, Germany) and insulin with a sensitive ELISA kit with crossreactivity with C-peptide and proinsulin less than 0.01% (Insulin ELISA, Mercodia, Uppsala, Sweden).
Fatty acid composition of serum phospholipids in a pooled serum sample from days 17 and 21 was analyzed as described (Wensing et al., 1999) . Briefly, total lipids were extracted from 100 ml serum according to the method of Bligh and Dyer (1959) . To separate phospholipids from the total lipid extract, aminopropyl-bonded silica columns (Varian, Harbor City, CA) were used (Kaluzny et al., 1985) . The phospholipids were then saponified and the resultant fatty acids were methylated into their corresponding FAME (Morrison and Smith, 1964) . Fatty acids were separated on an Autosystem (Perkin Elmer, Norwalk, CT) gas chromatograph, fitted with a silica gel column (Cp-sil 88 for FAME, 50 m Â 0.25 mm, film thickness 0.2 mm) with helium gas (130 kPa) as the carrier gas (Wensing et al., 1999) . Data were analyzed using Chromcard software (version 1.21, CE instruments, Milan, Italy). The fatty acid compositions of serum phospholipids were expressed in relative amounts (% of total fatty acids identified, w/w).
All samples from the same subject were analyzed in the same analytical run.
Statistics
The statistical power to detect a true difference in serum LDL cholesterol concentrations of 6% between the two treatments with an a of 0.05 was 80%. For serum lipids and lipoproteins, results of the two serum samples from days 17 and 21 were first averaged for each subject. Responses to treatments, which were calculated as the difference between values obtained at the end of two experimental periods, were analyzed by the one-sample t-test. Carry-over and time effects on these responses, which were absent for all variables, were analyzed as described (Pocock, 1987) . hsCRP responses were not normally distributed and were therefore analyzed using the non-parametric Wilcoxon's signed rank test.
The data were analyzed with SPSS 11 for Mac OS X package. A probability level (P-value) of less than 0.05 was considered statistically significant. Values are presented as means7s.d. Because hsCRP concentrations were not normally distributed, these values are presented as medians (ranges).
Results
Diets and dietary adherence
The mean daily energy intake and the composition of the two diets, as determined by the food-frequency questionnaires (Table 2) , agreed well with the prescribed composition of the diets. Total fat intake was on average 40 energy percent (En%), of which about 15 En% (or 39 g) was provided by the experimental fat and did not differ between the two diets (P ¼ 0.147). Changes in fatty acid intake were as expected and corresponded with the fatty acid composition of the experimental fats. Surprisingly, alcohol intake was slightly higher on the high-palmitic acid, trans-free diet (1.6 En% or 5.2 g) than on the high-oleic, low-trans diet (0.4 En% or 1.3 g).
Mean body weights at the end of each dietary period did not differ significantly between the two diets (P ¼ 0.080) and were 67.9710.7 kg on the high-palmitic acid, trans-free diet and 67.7711.0 kg on the high-oleic, low-trans diet.
Dietary adherence was confirmed by the fatty acid compositions of serum phospholipids (Table 3) . On the high-oleic acid, low-trans diet, the proportions of saturated fatty acids were decreased, which was because of a decrease in palmitic acid. In agreement with the composition of the experimental fat, the proportions of stearic acid, monounsaturated fatty acids and trans fatty acids were increased. Although the total proportion of polyunsaturated fatty acids did not change, the proportion of linoleic acid (C 18:2n-6 ) was decreased at the expense of arachidonic acid (C 20:4n-6 ). The proportions of the various n-3 polyunsaturated fatty acids did not change during the study.
Lipids, lipoprotein, CRP, glucose and insulin concentrations
Effects of the two different diets on serum lipid and lipoproteins concentrations are given in Table 4 . When compared with the high-palmitic acid, trans-free diet, serum total cholesterol concentrations decreased with À0.43 mmol/l (or À7.1%) on the high-oleic acid, low-trans diet. For LDL cholesterol, these values were respectively À0.34 mmol/l and À9.1%. HDL cholesterol and the total to HDL cholesterol ratio also decreased on the high-oleic acid, low-trans diet by respectively À0.06 mmol/l (or À3.1%) and À0.15 (or À3.5%). Serum triacylglycerol concentrations remained unaffected. Plasma hsCRP, glucose and insulin concentrations did not change during the study. Five subjects had, unrelated to the dietary treatments, on one or more occasion hsCRP concentrations 47 mg/l. When these subjects were excluded from the analysis, values were respectively 0.6 mg/l (range 0.18-5.5 mg/l) on the high-palmitic acid, trans-free diet and 0.7 mg/l (range 0.10-4.89 mg/l) on the high-oleic acid, low-trans diet. The median of the changes (0.02 mg/l) did not reach statistical significance (P ¼ 0.749).
Changes in lipids, lipoproteins, CRP, glucose and insulin concentrations were not related to gender, age or BMI and did not correlate with changes in alcohol intake.
Discussion
In the present study, we examined the effects of a semiliquid fat high in palmitic acid, which contained virtually no trans fatty acids, with a semiliquid fat high in oleic acid and a low amount of trans fatty acids. In contrast to many other studies, our aim was not to compare the effects of two different fatty acids, but of two fats with different fatty acid compositions, but with comparable functional characteristics, as required for preparation of specific types of foods. The disadvantage of this approach is that observed effects cannot be attributed to one single fatty acid. The advantage however is that the practical applications of the results are larger. Despite the slightly higher amount of trans fatty acids, we found that the high-oleic, low-trans fat lowered LDL cholesterol when compared with the high-palmitic acid, trans-free fat. This can be mainly attributed to the fact that both the intakes of stearic and oleic acids were increased at the expense of palmitic acid. The observed decrease in LDL cholesterol of À0.34 mmol/l however was nearly twice as high as the predicted reduction of À0.18 mmol/l (Mensink et al., 2003) . HDL cholesterol concentration also decreased, while no change was expected. As a consequence, the observed change of À0.15 in the total to HDL cholesterol ratio, which is considered a more specific marker for CHD than LDL cholesterol (Stampfer et al., 1991) , was close to the predicted value of À0.13. There is no obvious explanation for these discrepancies in observed and predicted values for LDL and HDL cholesterol. It is however possible that a small part of the discrepancy for LDL cholesterol is because of the amounts of plant sterols in rapeseed oil. Although not analyzed, it can be estimated that the high-oleic, low-trans fat (which was produced from rapeseed oil) provided an additional 200-250 mg of plant sterols (Pedersen et al., 2000) . This may have caused an additional decrease in LDL cholesterol of less than 0.04 mmol/l . For HDL cholesterol, it can be speculated that differences were related to daily alcohol intake, which was about 3 g higher on the high-palmitic acid, trans-free diet than on the high-oleic, low-trans fat diet. However, it is not likely that this has confounded the results. Based on the meta-analysis of Rimm et al. (1999) , it can be estimated that this small difference may only have caused an effect on serum HDL cholesterol of 0.01 mmol/l. The adverse effects of trans fatty acids on cardiovascular disease can be explained only partly through effects on the serum lipoprotein profile (Ascherio et al., 1999) . Recent studies however have provided evidence that trans fatty acid intake is positively associated with biomarkers of systemic inflammation related to cardiovascular risk. In the Nurses' Health Study, for example, increasing the intake of trans fatty acids from 0.9 to 2.1 En% increased CRP concentrations in a dose-dependent way by more than 73% (Lopez-Garcia et al., 2005) . Results of that study also suggested that markers of endothelial function were adversely affected by trans fatty acids. The difference in CRP concentrations between the first and second quintile was 18%. The difference in intake of trans fatty acids between these two quintiles was 0.6 En%, comparable with the difference in intakes in the present study. In agreement with the findings of Lichtenstein et al. (2003) , we found no effect of increasing trans fatty acid intake on CRP concentrations. In contrast, Baer et al. (2004) found that CRP concentrations were higher after consumption of trans fatty acids than after consumption of diets rich in oleic acid or carbohydrates. Surprisingly, when trans fatty acids were mixed with stearic acid, its CRP-increasing effect disappeared. Our low-trans product was also relatively high in stearic acid. Thus, there is no consistent evidence from dietary intervention studies that trans fatty acids increase CRP concentration. A possible explanation for the lack of effect on CRP concentrations in our study is that positive effects of other fatty acids counterbalanced the possible negative effects of trans fatty acids. a-Linolenic acid, for example, may be negatively associated with CRP concentrations (Bemelmans et al., 2004; Zhao et al., 2004) and the intake of this fatty acid was higher when subjects consumed the high-oleic, lowtrans fat. It is also possible that trans fatty acid intake in our study was simply too low to change CRP. Therefore, more intervention studies are needed to examine the comparative effects of fatty acids on CRP concentrations. In the Nurses' Health Study, the intake of trans fatty acids was positively related to the risk to develop type II diabetes. Subgroup analyses showed that effects were primarily observed in obese women, possibly owing to the fact that these women are already more insulin resistant compared with non-obese women (Salméron et al., 2001) . In other prospective cohort studies, no relationships were found (Meyer et al., 2001; Van Dam et al., 2002) . Dietary intervention studies also did not suggest adverse effects of trans fatty acids on insulin sensitivity (Louheranta et al., 1999; Lovejoy et al., 2002; Lichtenstein et al., 2003) . In only one study, consumption of 20 En% of energy from trans monounsaturated fatty acids did not change fasting concentrations of glucose and insulin in obese patients with type II diabetes, but did increase postprandial insulin secretions when compared with oleic acid (Christiansen et al., 1997) . Thus, intervention studies may suggest that only extreme high intake of trans fatty acids may affect postprandial insulinemia in obese subject with type II diabetes. At lower intakes, trans fatty acids did not change parameters related to glucose metabolism of healthy volunteers, which agrees with our findings. The high-oleic acid, low-trans fat provided only 0.6 En% from trans fatty acids. Still, proportions of trans fatty acids in serum phospholipids increased. Overall, changes in fatty acid compositions of serum phospholipids reflected differences in fatty acid intakes. The high-oleic acid, low-trans fat however slightly lowered the proportion of linoleic acid in plasma phospholipids, while intakes on the two diets were comparable. On the other hand, the proportion of arachidonic acid was increased. This does not suggest that at this level of trans fatty acid intake, the conversion of linoleic acid was not changed, which agrees with observations from other studies (Lichtenstein et al., 2003) .
In conclusion, we have demonstrated that a semiliquid fat rich in oleic acid and low in trans fatty acids does affect the serum lipoprotein profile more favorably when compared with a high-palmitic acid, trans-free fat. With this conclusion we do not suggest that trans fatty have no detrimental effects on cardiovascular risk. Our study does show, however, that it is not possible to pinpoint a fat or oil as good or bad without considering its complete fatty acid composition. Further, we have shown that two semiliquid fats with similar functional characteristics can have different effects on the serum lipoprotein profile.
